Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

approved   symbols : Gsk    save search

Breast Cancer Therapeutics Market 2023, USD 15.64 billion Growth is Expected between 2023 to 2028, Robust pipeline and new drug approvals to Boost Growth - Technavio
Published: 2024-01-30 (Crawled : 18:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510 twitter stocktwits trandingview |
Health Technology
| | O: 5.68% H: 0.77% C: 0.77%
AZNCF | News | $136.2 -4.19% 1.7K twitter stocktwits trandingview |
Health Technology
| | O: 3.41% H: 0.0% C: -2.45%
VTRS | News A | $11.235 -0.13% -0.13% 5.1M twitter stocktwits trandingview |
Health Technology
| | O: -0.08% H: 3.47% C: -0.25%
NVS | News | $95.12 0.81% -1.18% 2.4M twitter stocktwits trandingview |
Health Technology
| | O: -2.04% H: 0.19% C: -1.97%
GSK | News | $40.59 2.11% -0.36% 3.8M twitter stocktwits trandingview |
Health Technology
| | O: 4.04% H: 1.57% C: -3.02%
ABBV | News | $167.89 0.89% 0.0% 5.6M twitter stocktwits trandingview |
Health Technology
| | O: 0.5% H: 0.07% C: -0.81%
SNY | News | $47.125 1.78% 1.75% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: 1.75% H: 0.0% C: 0.0%
PBYI | $5.17 3.19% 3.09% 270K twitter stocktwits trandingview |
Health Technology
| | O: -0.1% H: 2.31% C: -1.26%
AZN | News | $70.12 2.29% 2.24% 4.8M twitter stocktwits trandingview |
Health Technology
| | O: 0.82% H: 0.12% C: -1.64%
AMGN | News | $271.98 1.13% 1.12% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.44% H: 0.2% C: -0.55%

drug breast expected cancer pipeline therapeutics growth market
US FDA Approves GSK’s AREXVY, the World’s First Respiratory Syncytial Virus (RSV) Vaccine for Older Adults
Published: 2023-05-03 (Crawled : 23:00) - biospace.com/
GSK | News | $40.59 2.11% -0.36% 3.8M twitter stocktwits trandingview |
Health Technology
| | O: 1.24% H: 1.14% C: 0.11%
AGEN A | $5.78 8.85% 7.97% 900K twitter stocktwits trandingview |
Health Technology
| | O: 1.42% H: 6.99% C: 4.2%

fda vaccine respiratory virus
Non-steroidal Anti-inflammatory Drugs Market Report 2023: Quick Authority Approvals by Governments and Increase in Government Initiatives Presents Opportunities
Published: 2023-04-27 (Crawled : 00:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510 twitter stocktwits trandingview |
Health Technology
| | O: 0.23% H: 0.0% C: 0.0%
SNYNF | News | $92.7 -2.18% 600K twitter stocktwits trandingview |
Health Technology
| | O: -1.21% H: 0.12% C: -2.76%
AZNCF | News | $136.2 -4.19% 1.7K twitter stocktwits trandingview |
Health Technology
| | O: -0.41% H: 0.79% C: 0.79%
RBGLY | News | $10.35 -2.05% 500K twitter stocktwits trandingview |
Manufacturing
| | O: 2.25% H: 0.31% C: 0.06%
PRGO | $30.06 -2.4% 0.0% 1.4M twitter stocktwits trandingview |
Health Technology
| | O: 0.11% H: 1.61% C: 1.42%
JNJ | News | $149.12 0.82% 0.0% 9.3M twitter stocktwits trandingview |
Health Technology
| | O: -0.12% H: 0.58% C: 0.55%
GSK | News | $40.59 2.11% -0.36% 3.8M twitter stocktwits trandingview |
Health Technology
| | O: -0.25% H: 0.97% C: 0.31%
LLY | News | $731.33 0.69% 0.0% 2.3M twitter stocktwits trandingview |
Health Technology
| | O: 1.96% H: 1.59% C: -0.54%
SNY | News | $47.125 1.78% 1.75% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: -2.09% H: 0.0% C: 0.0%
AZN | News | $70.12 2.29% 2.24% 4.8M twitter stocktwits trandingview |
Health Technology
| | O: -1.03% H: 1.02% C: 0.28%

report market
Diffuse large B-cell lymphoma (DLBCL) therapeutics market size to increase by USD 2,061.88 million between 2022 and 2027; Growth driven by increasing approval of therapeutics - Technavio
Published: 2023-03-10 (Crawled : 23:00) - prnewswire.com
AMGN | News | $271.98 1.13% 1.12% 2.1M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
CTIC | $9.09 0.05% 11M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
GLAXF | News | $20.2 -14.18% 510 twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
ABBV | News | $167.89 0.89% 0.0% 5.6M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
NVSEF | News | $93.6375 6.88% 82K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
NVS | News | $95.12 0.81% -1.18% 2.4M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
TEVJF | News | $12.37 -24.22% 380 twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
GSK | News | $40.59 2.11% -0.36% 3.8M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
ADCT | $4.69 -0.64% 0.0% 170K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

approval therapeutics growth market
US FDA grants regular approval for Jemperli for the treatment of patients with recurrent or advanced mismatch repair-deficient endometrial cancer
Published: 2023-02-10 (Crawled : 08:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510 twitter stocktwits trandingview |
Health Technology
| | O: -2.43% H: 0.66% C: 0.66%
GSK | News | $40.59 2.11% -0.36% 3.8M twitter stocktwits trandingview |
Health Technology
| | O: -1.07% H: 0.06% C: -0.55%
ANAB | $19.655 -1.08% -1.09% 140K twitter stocktwits trandingview |
Health Technology
| | O: 0.04% H: 1.27% C: -0.62%

treatment fda grants approval cancer
Neurologic Disorders Therapeutics Market Size to Grow by USD 33.46 billion, Approval Of Novel Drugs to Boost Market Growth - Technavio
Published: 2022-08-03 (Crawled : 04:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510 twitter stocktwits trandingview |
Health Technology
| | O: -1.8% H: 0.2% C: 0.0%
SNYNF | News | $92.7 -2.18% 600K twitter stocktwits trandingview |
Health Technology
| | O: -2.6% H: 0.0% C: -0.76%
NPCE | $13.98 0.0% 130K twitter stocktwits trandingview |
Manufacturing
| | O: 0.52% H: 3.71% C: -2.93%
NVS | News | $95.12 0.81% -1.18% 2.4M twitter stocktwits trandingview |
Health Technology
| | O: 0.11% H: 0.31% C: -0.34%
GSK | News | $40.59 2.11% -0.36% 3.8M twitter stocktwits trandingview |
Health Technology
| | O: -0.29% H: 0.24% C: -0.58%
ABBV | News | $167.89 0.89% 0.0% 5.6M twitter stocktwits trandingview |
Health Technology
| | O: 0.32% H: 0.0% C: 0.0%
SNY | News | $47.125 1.78% 1.75% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: -0.17% H: 0.12% C: -1.29%
BIIB | $194.1 -0.14% -0.15% 1.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.41% H: 3.35% C: 1.71%
ACAD | News | $17.0 1.07% 1.06% 1.2M twitter stocktwits trandingview |
Health Technology
| | O: 2.47% H: 2.8% C: -2.67%

approval therapeutics growth market
GSK Announces US FDA Approval of Benlysta (Belimumab) for Pediatric Patients With Active Lupus Nephritis
Published: 2022-07-27 (Crawled : 20:00) - biospace.com/
GSK | News | $40.59 2.11% -0.36% 3.8M twitter stocktwits trandingview |
Health Technology
| | O: -0.56% H: 3.36% C: 2.98%

fda active lupus approval
Global Panic Disorders Market Insights | Size | Shares | Trends | Growth | Industry Analysis [2020-2030] Panic disorders, also known as anxiety disorder deals with recurrent and unexpected panic attacks. PET-CT Scanner Devices Market: Competitive Landscape Analysis With Forecast by 2031 Wilmington, Delaware: According to the report, the global PET-CT scanner devices market was valued over US$ 200 Mn in 2020 and is projected to expand at a CAGR of ~3% from 2021 to 2031. Portal Hypertension Market Insights | Current Trends | Growth Opportunity | Global Industry Analysis [2020-2030] At present, treatment options for portal hypertension is limited due to the dearth of approval of specialized drugs. Spatial Genomics & Transcriptomics Market to Experience Significant Growth by 2027 Wilmington, Delaware: The spatial genomics & transcriptomics market is prognosticated to bring profitable growth during the assessment period of 2019-2027. Teleradiology Services Market to Make Great Impact in Near Future by 2031 Wilmington, Delaware: According to the report, the global teleradiology services market was valued over US$ 6.4 Bn in 2020. Anti-depressants Drugs and Therapies Market to Witness a Pronounce Growth by 2025 Wilmington, Delaware: Anti-depressants medications lower the symptoms of depression, dysthymia, chronic depression, and anxiety disorders. B-Cell Non-Hodgkin’s Lymphoma (NHL) Market to Offer Ample Growth Opportunities by 2027 Wilmington, Delaware: Non-Hodgkin’s lymphoma is a group of heterogeneous proliferative malignancies. Heightening Healthcare Spending Opening Growth Avenues for Collateral Ligament Stabilizer System Market, Reaching US$ 3.5 Billion in 2032: Fact.MR Study Fact.MR – A Market Research and Competitive Intelligence Provider: The global collateral ligament stabilizer system market is expected to reach US$ 3.5 Billion by the end of the 2022-2032 forecast period, growing at a CAGR of 6.1%, concludes a recently published report by Fact.MR. Breast Cancer Liquid Biopsy Market Trends, Growth, Analysis and Future Scope, 2026 Wilmington, Delaware: A biopsy is a tissue or cell sample taken from any part of the patient’s body and examined in the lab for the detection of cancer. Cerebral Palsy Market Size, Shares, Trends and Growth | Global Industry Analysis [2020-2030] The global cerebral palsy market is picking up steam due to increasing awareness about the condition amongst parents. Continuous Glucose Monitoring Market: Competitive Research and Precise Outlook 2021 to 2028 Wilmington, Delaware: The global continuous glucose monitoring market depicts the presence of a large competitive vendor landscape, says Transparency Market Research on the basis of a newly research report. Crow’s Feet Market Key Trends and Opportunity Analysis up to 2026 Albany NY, United States: The demand within the global crow’s feet market has been escalating on account of vital advancements in the field of dermatology in recent times. HIV Associated Lipodystrophy Syndrome Market Insights | Global Industry Analysis [2020-2030] HIV-associated lipodystrophy is a syndrome that are found in human immune-deficiency virus -infected patients who are being administered with active antiretroviral medications for the treatment of HIV infection. Global Mail Service Pharmacy Market | Size | Shares | Trends | Growth | Forecast [2020-2030]
Published: 2022-06-03 (Crawled : 06:00) - biospace.com/
GLAXF | News | $20.2 -14.18% 510 twitter stocktwits trandingview |
Health Technology
| | O: -1.55% H: 0.0% C: 0.0%
SNYNF | News | $92.7 -2.18% 600K twitter stocktwits trandingview |
Health Technology
| | O: -0.94% H: 0.0% C: 0.0%
AZNCF | News | $136.2 -4.19% 1.7K twitter stocktwits trandingview |
Health Technology
| | O: -0.4% H: 4.05% C: -1.35%
PFE | News A | $26.26 1.0% -0.08% 36M twitter stocktwits trandingview |
Health Technology
| | O: 0.57% H: 0.0% C: 0.0%
GSK | News | $40.59 2.11% -0.36% 3.8M twitter stocktwits trandingview |
Health Technology
| | O: -0.14% H: 0.0% C: 0.0%
LLY | News | $731.33 0.69% 0.0% 2.3M twitter stocktwits trandingview |
Health Technology
| | O: -2.25% H: 0.0% C: 0.0%
BMY | $49.14 0.43% 0.0% 7.9M twitter stocktwits trandingview |
Health Technology
| | O: -1.4% H: 0.0% C: 0.0%
SNY | News | $47.125 1.78% 1.75% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: -0.09% H: 0.0% C: 0.0%
NBIX | News M | $133.5 1.14% 1.12% 570K twitter stocktwits trandingview |
Health Technology
| | O: 2.29% H: 0.0% C: 0.0%
AZN | News | $70.12 2.29% 2.24% 4.8M twitter stocktwits trandingview |
Health Technology
| | O: -0.56% H: 0.82% C: -0.64%

lipodystrophy treatment research system active services report service growing hiv profitable hypertension genomics expected virus approval cancer growth group market breast cancer infections
Global Pharmaceutical API Manufacturing Market Report 2022-2030: Stringent Regulations for Approval of Pharmaceutical Drugs Restraining Growth
Published: 2022-04-12 (Crawled : 17:00) - prnewswire.com
AZNCF | News | $136.2 -4.19% 1.7K twitter stocktwits trandingview |
Health Technology
| | O: -0.86% H: 1.21% C: 1.21%
NVSEF | News | $93.6375 6.88% 82K twitter stocktwits trandingview |
Health Technology
| | O: 0.16% H: 0.22% C: 0.22%
NVS | News | $95.12 0.81% -1.18% 2.4M twitter stocktwits trandingview |
Health Technology
| | O: -0.48% H: 0.09% C: -0.68%
GSK | News | $40.59 2.11% -0.36% 3.8M twitter stocktwits trandingview |
Health Technology
| | O: -0.36% H: 0.0% C: 0.0%
LLY | News | $731.33 0.69% 0.0% 2.3M twitter stocktwits trandingview |
Health Technology
| | O: -0.77% H: 0.99% C: 0.49%
ALB | News | $112.29 0.13% 0.0% 2.3M twitter stocktwits trandingview |
Process Industries
| | O: 1.31% H: 2.06% C: -1.76%
ABBV | News | $167.89 0.89% 0.0% 5.6M twitter stocktwits trandingview |
Health Technology
| | O: -0.31% H: 0.74% C: -1.18%
SNY | News | $47.125 1.78% 1.75% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: -3.25% H: 0.0% C: 0.0%
AZN | News | $70.12 2.29% 2.24% 4.8M twitter stocktwits trandingview |
Health Technology
| | O: -2.32% H: 0.43% C: -0.55%

report approval growth market drug
ViiV Healthcare Announces US FDA Approval of Cabenuva (cabotegravir, rilpivirine) for Virologically Suppressed Adolescents Living With HIV Who Are 12 Years of Age or Older and Weigh at Least 35 kg
Published: 2022-03-29 (Crawled : 18:00) - biospace.com/
GLAXF | News | $20.2 -14.18% 510 twitter stocktwits trandingview |
Health Technology
| | O: -0.28% H: 0.0% C: -1.87%
PFE | News A | $26.26 1.0% -0.08% 36M twitter stocktwits trandingview |
Health Technology
| | O: 1.35% H: 0.15% C: -2.33%
JNJ | News | $149.12 0.82% 0.0% 9.3M twitter stocktwits trandingview |
Health Technology
| | O: 1.05% H: 0.0% C: 0.0%
GSK | News | $40.59 2.11% -0.36% 3.8M twitter stocktwits trandingview |
Health Technology
| | O: 1.17% H: 0.0% C: 0.0%

fda approval hiv order
ViiV Healthcare Announces US FDA Approval of Cabenuva (cabotegravir, rilpivirine) for Use Every Two Months, Expanding the Label of the First and Only Complete Long-Acting HIV Treatment
Published: 2022-02-01 (Crawled : 14:30) - biospace.com/
PFE | News A | $26.26 1.0% -0.08% 36M twitter stocktwits trandingview |
Health Technology
| | O: 0.09% H: 0.8% C: 0.63%
JNJ | News | $149.12 0.82% 0.0% 9.3M twitter stocktwits trandingview |
Health Technology
| | O: 0.22% H: 0.0% C: 0.0%
GSK | News | $40.59 2.11% -0.36% 3.8M twitter stocktwits trandingview |
Health Technology
| | O: 0.45% H: 0.53% C: 0.42%

treatment fda health fda approval thc approval hiv
GSK receives FDA accelerated approval for JEMPERLI (dostarlimab-gxly) for adult patients with mismatch repair-deficient (dMMR) recurrent or advanced solid tumors
Published: 2021-08-17 (Crawled : 21:00) - prnewswire.com
GSK | News | $40.59 2.11% -0.36% 3.8M twitter stocktwits trandingview |
Health Technology
| | O: 0.17% H: 0.66% C: -0.59%

fda solid tumors approval dostarlimab
Shingrix approved in the US for prevention of shingles in immunocompromised adults
Published: 2021-07-26 (Crawled : 14:00) - prnewswire.com
GSK | News | $40.59 2.11% -0.36% 3.8M twitter stocktwits trandingview |
Health Technology
| | O: -0.84% H: 0.17% C: -0.41%


FDA grants accelerated approval for GSK's JEMPERLI (dostarlimab-gxly) for women with recurrent or advanced dMMR endometrial cancer
Published: 2021-04-22 (Crawled : 21:00) - biospace.com/
GSK | News | $40.59 2.11% -0.36% 3.8M twitter stocktwits trandingview |
Health Technology
| | O: -1.15% H: 0.36% C: -0.34%

fda women cancer trial approval granted grant dostarlimab
FDA approves GSK's BENLYSTA as the first medicine for adult patients with active lupus nephritis in the US
Published: 2020-12-17 (Crawled : 14:12) - prnewswire.com
GSK | News | $40.59 2.11% -0.36% 3.8M twitter stocktwits trandingview |
Health Technology
| | O: 1.44% H: 0.16% C: -0.19%

fda lupus fda approval
Gainers vs Losers
75% 25%

Top 10 Gainers
MTTR | News M | $4.78 174.71% 63.6% 72M twitter stocktwits trandingview |

AGBA | $2.565 105.2% 51.27% 200M twitter stocktwits trandingview |
Finance

MLEC | $2.44 74.29% 42.62% 78M twitter stocktwits trandingview |
n/a

EDBL | News | $6.28 67.02% 40.13% 16M twitter stocktwits trandingview |

ATGL | $2.91 48.81% 32.8% 180K twitter stocktwits trandingview |

ZAPP | $0.2175 47.16% 32.05% 16M twitter stocktwits trandingview |
n/a

ONFO | $0.6075 38.38% 27.74% 7.3M twitter stocktwits trandingview |
n/a

VIVK | $1.48 38.32% 27.7% 530K twitter stocktwits trandingview |
Professional, Scientific, and T...

MNTS | $0.5 35.69% 26.3% 4.8M twitter stocktwits trandingview |

SDIG A | $3.635 35.13% 26.0% 1M twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.